Mohamed Yassine

Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal Cancer

Mario E. Lacouture, Edith P. Mitchell, Bilal Piperdi et al. · Journal of Clinical Oncology · 2010 · 475 citations

Medicine, Oncology, Pharmacology +16

Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions

Koen van Besien, M Koshy, Lisa Anderson-Shaw et al. · Bone Marrow Transplantation · 2001 · 67 citations

Medicine, Hematology, Cell Therapy +11

Regimen-related toxicity after fludarabine–melphalan conditioning: a prospective study of 31 patients with hematologic malignancies

Koen van Besien, Steven M. Devine, Amittha Wickrema et al. · Bone Marrow Transplantation · 2003 · 50 citations

Medicine, Hematology, Oncology +16

Exposure‐response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease

Niels Vande Casteele, Brian G. Feagan, Séverine Vermeire et al. · Alimentary Pharmacology & Therapeutics · 2017 · 46 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

The Efficacy and Safety of Panitumumab Administered Concomitantly With FOLFIRI or Irinotecan in Second-Line Therapy for Metastatic Colorectal Cancer: The Secondary Analysis From STEPP (Skin Toxicity Evaluation Protocol With Panitumumab) by KRAS Status

Edith P. Mitchell, Bilal Piperdi, Mario E. Lacouture et al. · Clinical Colorectal Cancer · 2011 · 41 citations

Medicine, Oncology, Pharmacology +14